Growth Metrics

Dynavax Technologies (DVAX) Short-term Investments: 2009-2025

Historic Short-term Investments for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $487.6 million.

  • Dynavax Technologies' Short-term Investments fell 24.37% to $487.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $487.6 million, marking a year-over-year decrease of 24.37%. This contributed to the annual value of $618.0 million for FY2024, which is 4.38% up from last year.
  • As of Q3 2025, Dynavax Technologies' Short-term Investments stood at $487.6 million, which was down 5.26% from $514.6 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Short-term Investments high stood at $644.7 million for Q3 2024, and its period low was $109.8 million during Q4 2021.
  • Over the past 3 years, Dynavax Technologies' median Short-term Investments value was $591.5 million (recorded in 2024), while the average stood at $561.8 million.
  • As far as peak fluctuations go, Dynavax Technologies' Short-term Investments spiked by 284.83% in 2022, and later declined by 24.37% in 2025.
  • Over the past 5 years, Dynavax Technologies' Short-term Investments (Quarterly) stood at $109.8 million in 2021, then skyrocketed by 284.83% to $422.4 million in 2022, then surged by 40.16% to $592.0 million in 2023, then rose by 4.38% to $618.0 million in 2024, then dropped by 24.37% to $487.6 million in 2025.
  • Its Short-term Investments stands at $487.6 million for Q3 2025, versus $514.6 million for Q2 2025 and $609.6 million for Q1 2025.